{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:29:32Z","timestamp":1783391372297,"version":"3.54.6"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Michael Mosier Defeat DIPG Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11060-020-03655-w","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T18:04:09Z","timestamp":1609783449000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Brain stem gliomas and current landscape"],"prefix":"10.1007","volume":"151","author":[{"given":"Brandon","family":"Wummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaney","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0973-0870","authenticated-orcid":false,"given":"Catherine","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"2","key":"3655_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0360-3016(97)00572-5","volume":"40","author":"CR Freeman","year":"1998","unstructured":"Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40(2):265\u2013271","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3655_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ et al (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's oncology group. Neuro-Oncology 13(4):410\u2013416","journal-title":"Neuro-Oncology"},{"issue":"Suppl 10","key":"3655_CR3","doi-asserted-by":"publisher","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","volume":"16","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT et al (2015) Alex's lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncology 16(Suppl 10):x1\u2013x36","journal-title":"Neuro-Oncology"},{"issue":"8","key":"3655_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","volume":"24","author":"SS Donaldson","year":"2006","unstructured":"Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24(8):1266\u20131272","journal-title":"J Clin Oncol"},{"issue":"10","key":"3655_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s003810050542","volume":"15","author":"CR Freeman","year":"1999","unstructured":"Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15(10):545\u2013553","journal-title":"Childs Nerv Syst"},{"issue":"7384","key":"3655_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231","journal-title":"Nature"},{"issue":"3","key":"3655_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251\u2013253","journal-title":"Nat Genet"},{"issue":"4","key":"3655_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425\u2013437","journal-title":"Cancer Cell"},{"issue":"5","key":"3655_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660\u2013672","journal-title":"Cancer Cell"},{"issue":"6134","key":"3655_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857\u2013861","journal-title":"Science"},{"issue":"5","key":"3655_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46(5):444\u2013450","journal-title":"Nat Genet"},{"issue":"20","key":"3655_CR12","first-page":"7404","volume":"61","author":"IF Pollack","year":"2001","unstructured":"Pollack IF et al (2001) Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res 61(20):7404\u20137407","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"3655_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/pr.2013.194","volume":"75","author":"KM Schroeder","year":"2014","unstructured":"Schroeder KM, Hoeman CM, Becher OJ (2014) Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr Res 75(1\u20132):205\u2013209","journal-title":"Pediatr Res"},{"issue":"4","key":"3655_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1215\/15228517-2008-029","volume":"10","author":"D Frappaz","year":"2008","unstructured":"Frappaz D et al (2008) Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial. Neuro-Oncology 10(4):599\u2013607","journal-title":"Neuro-Oncology"},{"issue":"8","key":"3655_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/jjco\/28.8.474","volume":"28","author":"YM Liu","year":"1998","unstructured":"Liu YM et al (1998) Prognostic factors and therapeutic options of radiotherapy in pediatric brain stem gliomas. Jpn J Clin Oncol 28(8):474\u2013479","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"3655_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s11060-011-0542-4","volume":"104","author":"L Negretti","year":"2011","unstructured":"Negretti L et al (2011) Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. J Neuro-Oncol 104(3):773\u2013777","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"3655_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3171\/jns.1986.65.6.0751","volume":"65","author":"AL Albright","year":"1986","unstructured":"Albright AL et al (1986) Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 65(6):751\u2013755","journal-title":"J Neurosurg"},{"issue":"4","key":"3655_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000056021","volume":"34","author":"JP Farmer","year":"2001","unstructured":"Farmer JP et al (2001) Brainstem gliomas. A 10-year institutional review. Pediatr Neurosurg 34(4):206\u2013214","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"3655_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.pcl.2014.09.011","volume":"62","author":"M Chintagumpala","year":"2015","unstructured":"Chintagumpala M, Gajjar A (2015) Brain tumors. Pediatr Clin N Am 62(1):167\u2013178","journal-title":"Pediatr Clin N Am"},{"issue":"4","key":"3655_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jocn.2005.05.015","volume":"13","author":"C Mauffrey","year":"2006","unstructured":"Mauffrey C (2006) Paediatric brainstem gliomas: prognostic factors and management. J Clin Neurosci 13(4):431\u2013437","journal-title":"J Clin Neurosci"},{"issue":"1","key":"3655_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-010-0301-y","volume":"102","author":"R Sethi","year":"2011","unstructured":"Sethi R et al (2011) Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. J Neuro-Oncol 102(1):121\u2013127","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"3655_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3171\/2016.4.PEDS16132","volume":"18","author":"R Singh","year":"2016","unstructured":"Singh R et al (2016) A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume. J Neurosurg Pediatr 18(5):565\u2013572","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"3655_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3171\/2013.11.PEDS136","volume":"13","author":"P Chittiboina","year":"2014","unstructured":"Chittiboina P et al (2014) Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas. J Neurosurg Pediatr 13(3):276\u2013282","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"3655_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jmri.22722","volume":"35","author":"A Poretti","year":"2012","unstructured":"Poretti A, Meoded A, Huisman TA (2012) Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 35(1):32\u201347","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"3655_CR25","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1177\/0883073816634855","volume":"31","author":"J Tisnado","year":"2016","unstructured":"Tisnado J et al (2016) Conventional and advanced imaging of diffuse intrinsic Pontine glioma. J Child Neurol 31(12):1386\u20131393","journal-title":"J Child Neurol"},{"issue":"6","key":"3655_CR26","first-page":"1026","volume":"33","author":"AL Albright","year":"1993","unstructured":"Albright AL et al (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer group. Neurosurgery 33(6):1026\u20131029 discussion 1029-30","journal-title":"Neurosurgery"},{"issue":"3","key":"3655_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1227\/00006123-199303000-00011","volume":"32","author":"DY Wen","year":"1993","unstructured":"Wen DY et al (1993) Targeted brain biopsy: a comparison of freehand computed tomography-guided and stereotactic techniques. Neurosurgery 32(3):407\u2013412 discussion 412-3","journal-title":"Neurosurgery"},{"issue":"4","key":"3655_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0090-3019(03)00048-X","volume":"59","author":"MJ McGirt","year":"2003","unstructured":"McGirt MJ et al (2003) MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 59(4):277\u2013281 discussion 281-2","journal-title":"Surg Neurol"},{"issue":"2","key":"3655_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3171\/jns.1994.81.2.0165","volume":"81","author":"M Bernstein","year":"1994","unstructured":"Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81(2):165\u2013168","journal-title":"J Neurosurg"},{"key":"3655_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.wneu.2017.03.059","volume":"102","author":"J Quick-Weller","year":"2017","unstructured":"Quick-Weller J et al (2017) Benefit and complications of frame-based stereotactic biopsy in old and very old patients. World Neurosurg 102:442\u2013448","journal-title":"World Neurosurg"},{"issue":"3","key":"3655_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439\u2013447","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3655_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46(5):451\u2013456","journal-title":"Nat Genet"},{"issue":"6021","key":"3655_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.1203280","volume":"331","author":"SJ Elsasser","year":"2011","unstructured":"Elsasser SJ, Allis CD, Lewis PW (2011) Cancer. New epigenetic drivers of cancers. Science 331(6021):1145\u20131146","journal-title":"Science"},{"issue":"6","key":"3655_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815\u2013827","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"3655_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","volume":"647","author":"JA Simon","year":"2008","unstructured":"Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647(1\u20132):21\u201329","journal-title":"Mutat Res"},{"issue":"7330","key":"3655_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D (2011) The Polycomb complex PRC2 and its mark in life. Nature 469(7330):343\u2013349","journal-title":"Nature"},{"issue":"9","key":"3655_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"KM Chan","year":"2013","unstructured":"Chan KM et al (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27(9):985\u2013990","journal-title":"Genes Dev"},{"issue":"12","key":"3655_CR38","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1074\/jbc.M808220200","volume":"284","author":"B Li","year":"2009","unstructured":"Li B et al (2009) Histone H3 lysine 36 dimethylation (H3K36me2) is sufficient to recruit the Rpd3s histone deacetylase complex and to repress spurious transcription. J Biol Chem 284(12):7970\u20137976","journal-title":"J Biol Chem"},{"issue":"4","key":"3655_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823\u2013837","journal-title":"Cell"},{"issue":"11","key":"3655_CR40","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1101657108","volume":"108","author":"M Monje","year":"2011","unstructured":"Monje M et al (2011) Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A 108(11):4453\u20134458","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3655_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR et al (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46(5):457\u2013461","journal-title":"Nat Genet"},{"issue":"1","key":"3655_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0012-1606(02)00037-4","volume":"255","author":"WA Gomes","year":"2003","unstructured":"Gomes WA, Mehler MF, Kessler JA (2003) Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255(1):164\u2013177","journal-title":"Dev Biol"},{"issue":"5","key":"3655_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38(5):525\u2013527","journal-title":"Nat Genet"},{"issue":"2","key":"3655_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11914-011-0046-3","volume":"9","author":"EM Shore","year":"2011","unstructured":"Shore EM, Kaplan FS (2011) Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Curr Osteoporos Rep 9(2):83\u201388","journal-title":"Curr Osteoporos Rep"},{"issue":"44","key":"3655_CR45","doi-asserted-by":"publisher","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","volume":"287","author":"A Chaikuad","year":"2012","unstructured":"Chaikuad A et al (2012) Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. J Biol Chem 287(44):36990\u201336998","journal-title":"J Biol Chem"},{"key":"3655_CR46","doi-asserted-by":"crossref","unstructured":"Hoeman, C.M., et al., ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nat Commun, 2019. 10(1): p. 1023","DOI":"10.1038\/s41467-019-08823-9"},{"key":"3655_CR47","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fonc.2015.00288","volume":"5","author":"A Parrales","year":"2015","unstructured":"Parrales A, Iwakuma T (2015) Targeting oncogenic mutant p53 for Cancer therapy. Front Oncol 5:288","journal-title":"Front Oncol"},{"issue":"6","key":"3655_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW et al (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6):957\u2013967","journal-title":"Cell"},{"issue":"5186","key":"3655_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.7973635","volume":"266","author":"SW Lowe","year":"1994","unstructured":"Lowe SW et al (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266(5186):807\u2013810","journal-title":"Science"},{"issue":"30","key":"3655_CR50","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS et al (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29(30):3999\u20134006","journal-title":"J Clin Oncol"},{"issue":"1","key":"3655_CR51","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98\u2013110","journal-title":"Cancer Cell"},{"issue":"1","key":"3655_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.wneu.2010.08.011","volume":"74","author":"N Sanai","year":"2010","unstructured":"Sanai N (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. World Neurosurg 74(1):4\u20135","journal-title":"World Neurosurg"},{"issue":"18","key":"3655_CR53","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","volume":"28","author":"BS Paugh","year":"2010","unstructured":"Paugh BS et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061\u20133068","journal-title":"J Clin Oncol"},{"issue":"12","key":"3655_CR54","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20(12):1394\u20131396","journal-title":"Nat Med"},{"issue":"7163","key":"3655_CR55","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger K et al (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163):731\u2013734","journal-title":"Nature"},{"issue":"47","key":"3655_CR56","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1073\/pnas.0707292104","volume":"104","author":"S Hong","year":"2007","unstructured":"Hong S et al (2007) Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A 104(47):18439\u201318444","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3655_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1101\/sqb.2010.75.020","volume":"75","author":"MR Hubner","year":"2010","unstructured":"Hubner MR, Spector DL (2010) Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harb Symp Quant Biol 75:43\u201349","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"12","key":"3655_CR58","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/nm.3769","volume":"20","author":"V Ramaswamy","year":"2014","unstructured":"Ramaswamy V, Remke M, Taylor MD (2014) An epigenetic therapy for diffuse intrinsic pontine gliomas. Nat Med 20(12):1378\u20131379","journal-title":"Nat Med"},{"issue":"4","key":"3655_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti A et al (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23(4):493\u2013500","journal-title":"Nat Med"},{"issue":"6200","key":"3655_CR60","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1255104","volume":"345","author":"HM Herz","year":"2014","unstructured":"Herz HM et al (2014) Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling. Science 345(6200):1065\u20131070","journal-title":"Science"},{"key":"3655_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/0470862637.ch20","volume":"259","author":"PA Marks","year":"2004","unstructured":"Marks PA et al (2004) Histone deacetylase inhibitors: development as cancer therapy. Novartis Found Symp 259:269\u2013281 discussion 281-8","journal-title":"Novartis Found Symp"},{"issue":"7","key":"3655_CR62","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827a","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):827","journal-title":"Nat Med"},{"issue":"1","key":"3655_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169485","volume":"12","author":"T Hennika","year":"2017","unstructured":"Hennika T et al (2017) Pre-clinical study of Panobinostat in Xenograft and genetically engineered murine diffuse intrinsic Pontine glioma models. PLoS One 12(1):e0169485","journal-title":"PLoS One"},{"issue":"5","key":"3655_CR64","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S et al (2017) Transcriptional dependencies in diffuse intrinsic Pontine glioma. Cancer Cell 31(5):635\u2013652 e6","journal-title":"Cancer Cell"},{"issue":"14","key":"3655_CR65","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1158\/0008-5472.CAN-17-3691","volume":"78","author":"S Pal","year":"2018","unstructured":"Pal S et al (2018) Dual HDAC and PI3K inhibition abrogates NFkappaB- and FOXM1-mediated DNA damage response to Radiosensitize pediatric high-grade gliomas. Cancer Res 78(14):4007\u20134021","journal-title":"Cancer Res"},{"issue":"3","key":"3655_CR66","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3171\/2018.2.PEDS17663","volume":"22","author":"WGB Singleton","year":"2018","unstructured":"Singleton WGB et al (2018) The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. J Neurosurg Pediatr 22(3):288\u2013296","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"3655_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","volume":"6","author":"GL Lin","year":"2018","unstructured":"Lin GL et al (2018) Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun 6(1):51","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3655_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","volume":"21","author":"NAP Lieberman","year":"2019","unstructured":"Lieberman NAP et al (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro-Oncology 21(1):83\u201394","journal-title":"Neuro-Oncology"},{"issue":"8","key":"3655_CR69","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","volume":"15","author":"WL Hwang","year":"2018","unstructured":"Hwang WL et al (2018) Safety of combining radiotherapy with immune-checkpoint inhibition. Nat Rev Clin Oncol 15(8):477\u2013494","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"3655_CR70","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","volume":"34","author":"E Bouffet","year":"2016","unstructured":"Bouffet E et al (2016) Immune checkpoint inhibition for Hypermutant glioblastoma Multiforme resulting from germline Biallelic mismatch repair deficiency. J Clin Oncol 34(19):2206\u20132211","journal-title":"J Clin Oncol"},{"issue":"19","key":"3655_CR71","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/cncr.30724","volume":"123","author":"RG Majzner","year":"2017","unstructured":"Majzner RG et al (2017) Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues. Cancer 123(19):3807\u20133815","journal-title":"Cancer"},{"issue":"21","key":"3655_CR72","first-page":"7462","volume":"63","author":"S Wintterle","year":"2003","unstructured":"Wintterle S et al (2003) Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 63(21):7462\u20137467","journal-title":"Cancer Res"},{"issue":"3","key":"3655_CR73","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","volume":"65","author":"F Hirano","year":"2005","unstructured":"Hirano F et al (2005) Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65(3):1089\u20131096","journal-title":"Cancer Res"},{"issue":"2","key":"3655_CR74","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","volume":"86","author":"J Zeng","year":"2013","unstructured":"Zeng J et al (2013) Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys 86(2):343\u2013349","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3655_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejca.2018.11.031","volume":"108","author":"M Auvray","year":"2019","unstructured":"Auvray M et al (2019) Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma. Eur J Cancer 108:33\u201340","journal-title":"Eur J Cancer"},{"issue":"9","key":"3655_CR76","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky JM et al (2016) Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 375(9):819\u2013829","journal-title":"N Engl J Med"},{"issue":"7","key":"3655_CR77","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","volume":"8","author":"F Skoulidis","year":"2018","unstructured":"Skoulidis F et al (2018) STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov 8(7):822\u2013835","journal-title":"Cancer Discov"},{"issue":"3","key":"3655_CR78","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11060-016-2190-1","volume":"129","author":"DT Blumenthal","year":"2016","unstructured":"Blumenthal DT et al (2016) Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors. J Neuro-Oncol 129(3):453\u2013460","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"3655_CR79","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","volume":"140","author":"C Kline","year":"2018","unstructured":"Kline C et al (2018) Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience. J Neuro-Oncol 140(3):629\u2013638","journal-title":"J Neuro-Oncol"},{"issue":"16","key":"3655_CR80","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-17-3061","volume":"24","author":"TJ Wildes","year":"2018","unstructured":"Wildes TJ et al (2018) Cross-talk between T cells and hematopoietic stem cells during adoptive cellular therapy for malignant glioma. Clin Cancer Res 24(16):3955\u20133966","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3655_CR81","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/hum.2012.041","volume":"23","author":"RA Morgan","year":"2012","unstructured":"Morgan RA et al (2012) Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Hum Gene Ther 23(10):1043\u20131053","journal-title":"Hum Gene Ther"},{"issue":"16","key":"3655_CR82","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371(16):1507\u20131517","journal-title":"N Engl J Med"},{"issue":"25","key":"3655_CR83","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","volume":"129","author":"RA Gardner","year":"2017","unstructured":"Gardner RA et al (2017) Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood 129(25):3322\u20133331","journal-title":"Blood"},{"issue":"3","key":"3655_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11060-012-1021-2","volume":"111","author":"Z Zhou","year":"2013","unstructured":"Zhou Z et al (2013) B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma. J Neuro-Oncol 111(3):257\u2013264","journal-title":"J Neuro-Oncol"},{"key":"3655_CR85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.omto.2019.07.002","volume":"14","author":"X Tang","year":"2019","unstructured":"Tang X et al (2019) B7-H3 as a novel CAR-T therapeutic target for glioblastoma. Mol Ther Oncolytics 14:279\u2013287","journal-title":"Mol Ther Oncolytics"},{"issue":"8","key":"3655_CR86","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner RG et al (2019) CAR T cells targeting B7-H3, a pan-Cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors. Clin Cancer Res 25(8):2560\u20132574","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3655_CR87","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","volume":"24","author":"CW Mount","year":"2018","unstructured":"Mount CW et al (2018) Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas. Nat Med 24(5):572\u2013579","journal-title":"Nat Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03655-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03655-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03655-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T20:39:58Z","timestamp":1697488798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03655-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03655-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical stadards"}},{"value":"CF has interest in iOncologi, an immunobiology company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethics approval was required for this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No consent was required for this review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No consent for publication was required for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}